Published in Clin Orthop Relat Res on July 09, 2015
Treatment of pathological fractures of the long bones. EFORT Open Rev (2017) 0.75
Decision support systems for incurable non-small cell lung cancer: a systematic review. BMC Med Inform Decis Mak (2017) 0.75
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol (2001) 10.16
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst (1998) 8.33
Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care (2002) 5.92
Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol (2011) 5.41
How to build and interpret a nomogram for cancer prognosis. J Clin Oncol (2008) 4.24
Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand (1995) 2.43
External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol (2014) 2.33
Estimation and Comparison of Receiver Operating Characteristic Curves. Stata J (2009) 2.07
Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol (2010) 2.05
The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst (2011) 2.00
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ (2015) 1.81
Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br (2005) 1.80
Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network. PLoS One (2011) 1.78
The impact of comorbidity on cancer survival: a review. Clin Epidemiol (2013) 1.68
How many patients? How many limbs? Analysis of patients or limbs in the orthopaedic literature: a systematic review. J Bone Joint Surg Am (2006) 1.57
Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol (2005) 1.46
The use and reporting of multiple imputation in medical research - a review. J Intern Med (2010) 1.34
Higher Charlson Comorbidity Index Scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res (2013) 1.27
Individual survival time prediction using statistical models. J Med Ethics (2005) 1.22
Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis. Surg Oncol (2013) 1.20
Diet and breast cancer: evidence that extremes in diet are associated with poor survival. J Clin Oncol (2003) 1.15
Patient survival after hip arthroplasty for metastatic disease of the hip. J Bone Joint Surg Am (2004) 1.02
The Social Security Death Index (SSDI) most accurately reflects true survival for older oncology patients. Am J Cancer Res (2013) 0.99
External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases. BMC Cancer (2012) 0.99
Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol (2009) 0.97
Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry. BMJ Open (2014) 0.87
Decreased body mass index is associated with poor prognosis in patients with multiple myeloma. Ann Hematol (2013) 0.84
A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients. Int J Radiat Oncol Biol Phys (2015) 0.80
Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol (2005) 4.10
A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96
Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology (2003) 3.86
Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am (2011) 3.23
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A (2012) 2.66
Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys (2003) 2.36
Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol (2007) 2.25
Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control (2005) 1.99
Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res (2004) 1.80
Infection in massive bone allografts. Clin Orthop Relat Res (2005) 1.73
Giant cell tumor of the mobile spine: a review of 49 cases. Spine (Phila Pa 1976) (2012) 1.65
Giant cell tumor of bone. J Am Acad Orthop Surg (2013) 1.59
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol (2012) 1.51
Survivorship analysis of 141 modular metallic endoprostheses at early followup. Clin Orthop Relat Res (2004) 1.50
Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys (2006) 1.50
Allografts about the Knee in Young Patients with High-Grade Sarcoma. Clin Orthop Relat Res (2004) 1.45
Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. J Neurosurg (2012) 1.45
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma. Cancer (2014) 1.43
Survival data for patients with malignant schwannoma. Clin Orthop Relat Res (2004) 1.43
Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys (2007) 1.42
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PLoS One (2009) 1.40
Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg (2002) 1.39
MicroRNA Involvement in Osteosarcoma. Sarcoma (2012) 1.38
Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal Radiol (2002) 1.37
Distal lower extremity sarcomas: frequency of occurrence and patient survival rate. Foot Ankle Int (2004) 1.27
Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys (2008) 1.27
Unicameral bone cyst: a retrospective study of three surgical treatments. Clin Orthop Relat Res (2008) 1.27
Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One (2011) 1.24
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol (2008) 1.23
Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol (2010) 1.19
Long-term followup of proximal femoral allografts. Clin Orthop Relat Res (2002) 1.19
Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis. Clin Cancer Res (2003) 1.18
Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures. Clin Orthop Relat Res (2011) 1.18
Bone cancer. J Natl Compr Canc Netw (2013) 1.17
Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol (2014) 1.17
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res (2010) 1.16
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One (2010) 1.16
Leiomyosarcoma of somatic soft tissues. Clin Orthop Relat Res (2004) 1.15
Internal hemipelvectomy for the management of pelvic sarcomas. Surg Oncol Clin N Am (2005) 1.15
Total femur replacement procedures in tumor treatment. Clin Orthop Relat Res (2005) 1.14
Treatment of giant cell tumors with allograft transplants: a 30-year study. Clin Orthop Relat Res (2005) 1.11
Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol (2012) 1.09
Management of acral myxoinflammatory fibroblastic sarcoma. Cancer (2010) 1.09
Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations. Am J Surg Pathol (2013) 1.08
A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther (2009) 1.07
Surgical treatment of hemangiomas of soft tissue. Clin Orthop Relat Res (2002) 1.07
Outcome after reconstruction of the proximal humerus for tumor resection: a systematic review. Clin Orthop Relat Res (2014) 1.06
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma. BMC Cancer (2009) 1.05
Soft tissue sarcoma resection volume associated with wound-healing complications. Clin Orthop Relat Res (2007) 1.05
Magnetic resonance imaging-guided percutaneous biopsy of musculoskeletal lesions. J Bone Joint Surg Am (2007) 1.04
ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res (2011) 1.04
Do corresponding authors take responsibility for their work? A covert survey. Clin Orthop Relat Res (2014) 1.04
Paget's sarcoma: a historical and outcome review. Clin Orthop Relat Res (2005) 1.04
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines. Mol Cancer Ther (2009) 1.04
MRI-guided percutaneous cryotherapy for soft-tissue and bone metastases: initial experience. AJR Am J Roentgenol (2007) 1.04
Malignant tumors of the pelvis: an outcome study. Clin Orthop Relat Res (2004) 1.03
Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis. J Orthop Res (2010) 1.03
Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas. Int J Radiat Oncol Biol Phys (2010) 1.02
Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells. Cancer Chemother Pharmacol (2010) 1.01
The kinase Mirk is a potential therapeutic target in osteosarcoma. Carcinogenesis (2009) 1.01
Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer (2011) 1.01
Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway. BMC Cancer (2010) 1.00
Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas. Cancer (2011) 1.00
Synovial chondromatosis of the foot. Clin Orthop Relat Res (2004) 1.00
Alveolar soft part sarcoma: a rare and enigmatic entity. Clin Orthop Relat Res (2005) 0.99
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation. Clin Cancer Res (2012) 0.99
Malignant transformation of synovial chondromatosis of the shoulder to chondrosarcoma. A case report. J Bone Joint Surg Am (2007) 0.99
Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series. Am J Surg Pathol (2014) 0.98
Characterization and analysis of human chordoma cell lines. Spine (Phila Pa 1976) (2010) 0.97
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Cancer Lett (2010) 0.97
Comparison of quality of life after amputation or limb salvage. Clin Orthop Relat Res (2002) 0.95
Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas. Clin Cancer Res (2009) 0.95
Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma. PLoS One (2013) 0.95
Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone. Am J Surg Pathol (2016) 0.94
Results of radiation therapy performed after unplanned surgery (without re-excision) for soft tissue sarcomas. J Surg Oncol (2005) 0.94
β-Catenin mutation status and outcomes in sporadic desmoid tumors. Oncologist (2013) 0.94
NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance. PLoS One (2009) 0.93
What are the functional results and complications from allograft reconstruction after partial hemipelvectomy of the pubis? Clin Orthop Relat Res (2014) 0.93
An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control. Int J Radiat Oncol Biol Phys (2009) 0.93